AR069958A1 - Metodo para producir una proteina heterologa de interes - Google Patents

Metodo para producir una proteina heterologa de interes

Info

Publication number
AR069958A1
AR069958A1 ARP080105694A ARP080105694A AR069958A1 AR 069958 A1 AR069958 A1 AR 069958A1 AR P080105694 A ARP080105694 A AR P080105694A AR P080105694 A ARP080105694 A AR P080105694A AR 069958 A1 AR069958 A1 AR 069958A1
Authority
AR
Argentina
Prior art keywords
interest
protein
producing
heterology
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ARP080105694A
Other languages
English (en)
Inventor
Hitto Kaufman
Eric Becker
Martin Fusseneger
Joey M Studts
Ren-Wang Peng
Lore Florin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of AR069958A1 publication Critical patent/AR069958A1/es
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.

Abstract

También se proveen un vector de expresion, una célula, composiciones farmacéuticas, método para tratar el cáncer, enfermedades autoinmunes e inflamacion y uso diagnostico. Reivindicacion 1: Un método para producir una proteína heterologa de interés en una célula, caracterizado porque comprende: a) aumentar la expresion de al menos un gen que codifica una proteína del grupo de proteínas SEC1/Munc 18 (proteínas SM) y b) llevar a efecto la expresion de dicha proteína heterologa de interés.
ARP080105694A 2007-12-20 2008-12-23 Metodo para producir una proteina heterologa de interes Pending AR069958A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07150254 2007-12-20
EP08152829 2008-03-17

Publications (1)

Publication Number Publication Date
AR069958A1 true AR069958A1 (es) 2010-03-03

Family

ID=40344722

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080105694A Pending AR069958A1 (es) 2007-12-20 2008-12-23 Metodo para producir una proteina heterologa de interes

Country Status (14)

Country Link
US (1) US20090247609A1 (es)
EP (1) EP2225389A1 (es)
JP (1) JP2011505850A (es)
KR (1) KR20100099190A (es)
CN (1) CN101903529A (es)
AR (1) AR069958A1 (es)
AU (1) AU2008340652A1 (es)
BR (1) BRPI0821389A2 (es)
CA (1) CA2709645A1 (es)
EA (1) EA201000945A1 (es)
IL (1) IL205239A0 (es)
NZ (1) NZ586037A (es)
TW (1) TW200932907A (es)
WO (1) WO2009080299A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG178940A1 (en) 2009-09-18 2012-04-27 Selexis Sa Products and methods for enhanced transgene expression and processing
TWI641687B (zh) * 2012-05-29 2018-11-21 美商再生元醫藥公司 生產細胞株增強子
EP3536797B1 (en) 2013-02-01 2023-01-04 Selexis S.A. Enhanced transgene expression and processing
CN107207586B (zh) * 2014-12-19 2021-07-13 莫茨药物股份两合公司 用于测定BoNT/E在细胞中的生物活性的装置和方法
CN106554973B (zh) * 2015-09-30 2020-05-22 北京吉尚立德生物科技有限公司 一种cho细胞分泌能力评价系统
WO2023155881A1 (en) * 2022-02-18 2023-08-24 Tsinghua University Methods for regulating secretion via migrasomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI924494A0 (fi) * 1992-10-06 1992-10-06 Valtion Teknillinen Oekad produktion av avsoendrarde proteiner i eukaryotiska rekombinantceller
EP1003889A1 (en) * 1997-08-05 2000-05-31 Chiron Corporation NOVEL $i(PICHIA PASTORIS) GENE SEQUENCES AND METHODS FOR THEIR USE
AU2002952550A0 (en) * 2002-11-08 2002-11-21 The University Of Queensland Modulating TNFalpha Secretion

Also Published As

Publication number Publication date
IL205239A0 (en) 2010-11-30
WO2009080299A1 (en) 2009-07-02
EP2225389A1 (en) 2010-09-08
EA201000945A1 (ru) 2011-02-28
WO2009080299A8 (en) 2010-04-15
NZ586037A (en) 2012-08-31
US20090247609A1 (en) 2009-10-01
AU2008340652A1 (en) 2009-07-02
TW200932907A (en) 2009-08-01
BRPI0821389A2 (pt) 2015-06-16
JP2011505850A (ja) 2011-03-03
CN101903529A (zh) 2010-12-01
CA2709645A1 (en) 2009-07-02
KR20100099190A (ko) 2010-09-10

Similar Documents

Publication Publication Date Title
BR112018067696A2 (pt) membros de ligação à pd-l1
PE20200006A1 (es) Nuevas moleculas de union antigeno biespecificas capaces de unirse especificamente cd40 y a fap
ECSP18073836A (es) Moléculas de unión a bcma y métodos de uso de las mismas
BR112013003823A2 (pt) conjugados de peptídeo terapêutico-políemro, partículas, composições, e métodos relacionados
GT201000148A (es) Anticuerpos antimesotelina y usos de los mismos
UY37829A (es) Muteínas de interleucina 21 y métodos de tratamiento
CL2007003649A1 (es) Un conjugado de molecula asociado a anticuerpo monoclonal humano anti-cd70; composicion que comprende al conjugado de molecula asociado a anticuerpo; metodo de inhibicion del crecimiento de celulas tumorales que expresan cd70.
CR20170419A (es) Nuevos péptidos y nueva combinación de péptidos para el uso en la inmunoterapia contra el cáncer de páncreas y otros tipos de cáncer.
BR112017014551A2 (pt) ?anticorpo, construção de ácido nucleico, vetor de expressão, célula hospedeira, composição, métodos para tratamento de uma doença, para produção de um anticorpo biespecífico e para detecção da possível ocorrência de reticulação entre células com expressão de cd3 e cd20 em uma amostra derivada de um paciente, uso de um anticorpo biespecífico, e, kit?
PE20140673A1 (es) Nuevos moduladores y metodos para su uso
ECSP11011297A (es) Proteinas ligadoras il-17
BR112012011332A2 (pt) agentes direcionados para gadd45beta
EA201700181A1 (ru) Композиции аденозиндеаминазы-2 (ада-2), их варианты и способы использования
CO6710903A2 (es) Un anticuerpo que reconoce y se une específicamente con un fosfo-epítope en la proteína tau de mamífero o en uno de sus fragmentos y una composición comprendiendo el mismo
BR112015014751A2 (pt) anticorpos anti-tau humanos
EA200870021A1 (ru) Человеческие моноклональные антитела к фукозил-gm1 и способы применения анти-фукозил-gm1 антител
CO6470802A2 (es) Péptido auxiliar del antígeno del cáncer
AR069958A1 (es) Metodo para producir una proteina heterologa de interes
DOP2014000083A (es) Inmunoenlazadores dirigidos contra el tnf
AR067666A1 (es) Proteinas de union al antigeno del receptor de il-18
MX2009005189A (es) Anticuerpos humanos monoclonales para btla y metodos de uso.
PE20140190A1 (es) Moduladores de proteinas notum y metodos de uso
ECSP12012272A (es) Proteínas que se unen al tnf-?
PE20091193A1 (es) Proteinas humanas de union a antigenos del gm-csf
MX2010000537A (es) Anticuerpos monoclonales contra glipicano-3.

Legal Events

Date Code Title Description
FB Suspension of granting procedure